{"title":"自体骨软骨原发移植治疗距骨囊性骨软骨病变。","authors":"Yusuf Onur Kızılay, Murat Kezer","doi":"10.7547/24-052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The need for intra-articular osteotomy and potential complications at the donor site may lead some surgeons to avoid using the osteochondral autograft transfer method as a primary surgery, instead considering it a revision procedure for osteochondral lesions of the talus. In this retrospective study, we hypothesized that the primary application of osteochondral autograft transfer in cystic talar osteochondral lesions would yield good results and intra-articular osteotomy and donor site would not have a negative effect on long-term clinical outcomes. The primary objective of this study was to demonstrate that osteochondral autograft transfer can be safely applied as a primary treatment for cystic talar osteochondral lesions.</p><p><strong>Methods: </strong>In our study, 21 patients underwent primary osteochondral autograft transfer for cystic talar osteochondral lesions. Demographic data of patients, including age, gender, and body mass index, as well as duration of symptoms, etiology of the lesion, location of the lesion, and follow-up duration were recorded from our medical records. The clinical evaluation used the visual analog scale for pain, function, and satisfaction along with the American Orthopaedic Foot & Ankle Society score. In addition, the magnetic resonance observation of cartilage repair tissue scale was used for evaluation of graft healing.</p><p><strong>Results: </strong>The mean follow-up time was 32 months. According to the results of the study, compared with the preoperative status, statistically significant improvement was observed in visual analog scale pain, function, and satisfaction scores as well as in the American College of Foot and Ankle Surgeons score. In addition to these findings, it was observed that there was no negative effect of intra-articular osteotomy and donor site on long-term results.</p><p><strong>Conclusions: </strong>Our study showed that osteochondral autograft transfer can be safely applied as primary surgery in cystic talar osteochondral lesions.</p>","PeriodicalId":17241,"journal":{"name":"Journal of the American Podiatric Medical Association","volume":"115 4","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Primary Osteochondral Autograft Transfer for the Treatment of Cystic Osteochondral Lesions of the Talus.\",\"authors\":\"Yusuf Onur Kızılay, Murat Kezer\",\"doi\":\"10.7547/24-052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The need for intra-articular osteotomy and potential complications at the donor site may lead some surgeons to avoid using the osteochondral autograft transfer method as a primary surgery, instead considering it a revision procedure for osteochondral lesions of the talus. In this retrospective study, we hypothesized that the primary application of osteochondral autograft transfer in cystic talar osteochondral lesions would yield good results and intra-articular osteotomy and donor site would not have a negative effect on long-term clinical outcomes. The primary objective of this study was to demonstrate that osteochondral autograft transfer can be safely applied as a primary treatment for cystic talar osteochondral lesions.</p><p><strong>Methods: </strong>In our study, 21 patients underwent primary osteochondral autograft transfer for cystic talar osteochondral lesions. Demographic data of patients, including age, gender, and body mass index, as well as duration of symptoms, etiology of the lesion, location of the lesion, and follow-up duration were recorded from our medical records. The clinical evaluation used the visual analog scale for pain, function, and satisfaction along with the American Orthopaedic Foot & Ankle Society score. In addition, the magnetic resonance observation of cartilage repair tissue scale was used for evaluation of graft healing.</p><p><strong>Results: </strong>The mean follow-up time was 32 months. According to the results of the study, compared with the preoperative status, statistically significant improvement was observed in visual analog scale pain, function, and satisfaction scores as well as in the American College of Foot and Ankle Surgeons score. In addition to these findings, it was observed that there was no negative effect of intra-articular osteotomy and donor site on long-term results.</p><p><strong>Conclusions: </strong>Our study showed that osteochondral autograft transfer can be safely applied as primary surgery in cystic talar osteochondral lesions.</p>\",\"PeriodicalId\":17241,\"journal\":{\"name\":\"Journal of the American Podiatric Medical Association\",\"volume\":\"115 4\",\"pages\":\"\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the American Podiatric Medical Association\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7547/24-052\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Podiatric Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7547/24-052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
Primary Osteochondral Autograft Transfer for the Treatment of Cystic Osteochondral Lesions of the Talus.
Background: The need for intra-articular osteotomy and potential complications at the donor site may lead some surgeons to avoid using the osteochondral autograft transfer method as a primary surgery, instead considering it a revision procedure for osteochondral lesions of the talus. In this retrospective study, we hypothesized that the primary application of osteochondral autograft transfer in cystic talar osteochondral lesions would yield good results and intra-articular osteotomy and donor site would not have a negative effect on long-term clinical outcomes. The primary objective of this study was to demonstrate that osteochondral autograft transfer can be safely applied as a primary treatment for cystic talar osteochondral lesions.
Methods: In our study, 21 patients underwent primary osteochondral autograft transfer for cystic talar osteochondral lesions. Demographic data of patients, including age, gender, and body mass index, as well as duration of symptoms, etiology of the lesion, location of the lesion, and follow-up duration were recorded from our medical records. The clinical evaluation used the visual analog scale for pain, function, and satisfaction along with the American Orthopaedic Foot & Ankle Society score. In addition, the magnetic resonance observation of cartilage repair tissue scale was used for evaluation of graft healing.
Results: The mean follow-up time was 32 months. According to the results of the study, compared with the preoperative status, statistically significant improvement was observed in visual analog scale pain, function, and satisfaction scores as well as in the American College of Foot and Ankle Surgeons score. In addition to these findings, it was observed that there was no negative effect of intra-articular osteotomy and donor site on long-term results.
Conclusions: Our study showed that osteochondral autograft transfer can be safely applied as primary surgery in cystic talar osteochondral lesions.
期刊介绍：
The Journal of the American Podiatric Medical Association, the official journal of the Association, is the oldest and most frequently cited peer-reviewed journal in the profession of foot and ankle medicine. Founded in 1907 and appearing 6 times per year, it publishes research studies, case reports, literature reviews, special communications, clinical correspondence, letters to the editor, book reviews, and various other types of submissions. The Journal is included in major indexing and abstracting services for biomedical literature.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
